Suppr超能文献

种族差异对糖尿病视网膜病变的患病率和危险因素:新加坡眼病流行病学研究。

Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study.

机构信息

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore; Duke-National University of Singapore Medical School, Singapore.

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

出版信息

Ophthalmology. 2018 Apr;125(4):529-536. doi: 10.1016/j.ophtha.2017.10.026. Epub 2017 Dec 6.

Abstract

PURPOSE

To evaluate the prevalence and risk factors for diabetic retinopathy (DR) in the Singapore Epidemiology of Eye Diseases (SEED) Study.

DESIGN

Population-based, cross-sectional study.

PARTICIPANTS

Persons of Malay, Indian, and Chinese ethnicity aged 40+ years, living in Singapore.

METHODS

Diabetes was defined as nonfasting plasma glucose ≥200 mg/dl (11.1 mmol/l), glycated hemoglobin A1c (HbA1c) >6.5%, self-reported physician-diagnosed diabetes, or the use of glucose-lowering medication. Retinal photographs, were graded for the presence and severity of DR using the modified Airlie House classification system.

MAIN OUTCOME MEASURES

Diabetic retinopathy, diabetic macular edema (DME), vision-threatening diabetic retinopathy (VTDR), defined as the presence of severe nonproliferative or proliferative DR, or clinically significant macular edema (CSME).

RESULTS

Of the 10 033 subjects, 2877 (28.7%) had diabetes and gradable photographs for analysis. The overall age-standardized prevalence (95% confidence interval [CI]) was 28.2% (25.9-30.6) for any DR, 7.6% (6.5-9.0) for DME, and 7.7% (6.6-9.0) for VTDR. Indians had a higher prevalence of any DR (30.7% vs. 26.2% in Chinese and 25.5% in Malays, P = 0.012); a similar trend was noted for any DME (P = 0.001) and CSME (P = 0.032). Independent risk factors for any DR were Indian ethnicity (odds ratio [OR], 1.41; 95% CI, 1.09-1.83, vs. Chinese), diabetes duration (OR, 1.10; 95% CI, 1.08-1.11, per year), HbA1c (OR, 1.25; 95% CI, 1.18-1.32, per %), serum glucose (OR, 1.03; 95% CI, 1.00-1.06, per mmol/l), and systolic blood pressure (OR, 1.14; 95% CI, 1.09-1.19, per 10 mmHg). Diastolic blood pressure (OR, 0.74; 95% CI, 0.65-0.84, per 10 mmHg increase), total cholesterol (OR, 0.87; 95% CI, 0.80-0.95, per mmol/l increase), and low-density lipoprotein (LDL) cholesterol (OR, 0.83; 95% CI, 0.74-0.92, per mmol/l increase) were associated with lower odds of any DR. Risk factors were largely similar across the 3 ethnic groups.

CONCLUSIONS

Indian Singaporeans have a higher prevalence of DR and DME compared with Chinese and Malays. Major risk factors for DR in this study were similar across the 3 ethnic groups. Addressing these risk factors may reduce the impact of DR in Asia, regardless of ethnicity.

摘要

目的

评估新加坡眼病流行病学研究(SEED 研究)中糖尿病视网膜病变(DR)的患病率和危险因素。

设计

基于人群的横断面研究。

参与者

40 岁及以上、居住在新加坡的马来、印度和华人族群。

方法

糖尿病的定义是非空腹血糖≥200mg/dl(11.1mmol/l)、糖化血红蛋白 A1c(HbA1c)>6.5%、经医生诊断的糖尿病、或使用降血糖药物。使用改良的 Airlie House 分类系统对视网膜照片进行分级,以评估 DR 的存在和严重程度。

主要观察指标

DR、糖尿病黄斑水肿(DME)、威胁视力的 DR(VTDR),定义为严重非增殖性或增殖性 DR 或有临床意义的黄斑水肿(CSME)的存在。

结果

在 10033 名受试者中,有 2877 名(28.7%)患有糖尿病,可对照片进行分级分析。总体年龄标准化患病率(95%置信区间[CI])为:任何 DR 的患病率为 28.2%(25.9-30.6),DME 的患病率为 7.6%(6.5-9.0),VTDR 的患病率为 7.7%(6.6-9.0)。与华人(26.2%)和马来人(25.5%)相比,印度人任何 DR 的患病率更高(30.7%,P=0.012);DME(P=0.001)和 CSME(P=0.032)也有类似的趋势。任何 DR 的独立危险因素包括印度裔(优势比[OR],1.41;95%CI,1.09-1.83,与华人相比)、糖尿病病程(OR,1.10;95%CI,1.08-1.11,每年)、HbA1c(OR,1.25;95%CI,1.18-1.32,每%)、血清葡萄糖(OR,1.03;95%CI,1.00-1.06,每 mmol/l)和收缩压(OR,1.14;95%CI,1.09-1.19,每 10mmHg 增加)。舒张压(OR,0.74;95%CI,0.65-0.84,每增加 10mmHg)、总胆固醇(OR,0.87;95%CI,0.80-0.95,每增加 1mmol/l)和低密度脂蛋白胆固醇(OR,0.83;95%CI,0.74-0.92,每增加 1mmol/l)与任何 DR 的低几率相关。这些危险因素在 3 个族群中基本相似。

结论

与华人及马来人相比,新加坡印度裔人群的 DR 和 DME 患病率更高。本研究中 DR 的主要危险因素在 3 个族群中基本相似。无论种族如何,解决这些危险因素可能会降低亚洲地区 DR 的影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验